Business Description
Atomo Diagnostics Ltd
ISIN : AU0000080327
Share Class Description:
ASX:AT1: Ordinary SharesDescription
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 7.01 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.14 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -6.66 | |||||
Beneish M-Score | -5.58 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -39 | |||||
3-Year EBITDA Growth Rate | 5.9 | |||||
3-Year EPS without NRI Growth Rate | 7.2 | |||||
3-Year FCF Growth Rate | 30.7 | |||||
3-Year Book Growth Rate | -40.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 40.19 | |||||
9-Day RSI | 41.49 | |||||
14-Day RSI | 40.07 | |||||
3-1 Month Momentum % | -42.65 | |||||
6-1 Month Momentum % | -45.83 | |||||
12-1 Month Momentum % | 39.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.78 | |||||
Quick Ratio | 2.14 | |||||
Cash Ratio | 1.4 | |||||
Days Inventory | 297.07 | |||||
Days Sales Outstanding | 130.19 | |||||
Days Payable | 127.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9 | |||||
Shareholder Yield % | -9.61 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 40.75 | |||||
Operating Margin % | -185.68 | |||||
Net Margin % | -114.12 | |||||
EBITDA Margin % | -102.38 | |||||
FCF Margin % | -64.1 | |||||
OCF Margin % | -62.98 | |||||
ROE % | -56.74 | |||||
ROA % | -42.6 | |||||
ROIC % | -121.46 | |||||
3-Year ROIIC % | -20.54 | |||||
ROC (Joel Greenblatt) % | -233.19 | |||||
ROCE % | -71 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 3.4 | |||||
PB Ratio | 2.13 | |||||
Price-to-Tangible-Book | 1.7 | |||||
EV-to-EBIT | -2.4 | |||||
EV-to-Forward-EBIT | 110.67 | |||||
EV-to-EBITDA | -3.45 | |||||
EV-to-Forward-EBITDA | 45.79 | |||||
EV-to-Revenue | 3.53 | |||||
EV-to-Forward-Revenue | 2.19 | |||||
EV-to-FCF | -5.51 | |||||
Price-to-GF-Value | 0.85 | |||||
| Price-to-Net-Current-Asset-Value | 1.7 | |||||
Earnings Yield (Greenblatt) % | -41.67 | |||||
FCF Yield % | -14.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Atomo Diagnostics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 3.485 | ||
| EPS (TTM) (A$) | -0.005 | ||
| Beta | 0.9093 | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 84.24 | ||
| 14-Day RSI | 40.07 | ||
| 14-Day ATR (A$) | 0.001116 | ||
| 20-Day SMA (A$) | 0.017425 | ||
| 12-1 Month Momentum % | 39.29 | ||
| 52-Week Range (A$) | 0.014 - 0.048 | ||
| Shares Outstanding (Mil) | 901.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Atomo Diagnostics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Atomo Diagnostics Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Atomo Diagnostics Ltd Frequently Asked Questions
What is Atomo Diagnostics Ltd(ASX:AT1)'s stock price today?
The current price of ASX:AT1 is A$0.02. The 52 week high of ASX:AT1 is A$0.05 and 52 week low is A$0.01.
When is next earnings date of Atomo Diagnostics Ltd(ASX:AT1)?
The next earnings date of Atomo Diagnostics Ltd(ASX:AT1) is .
Does Atomo Diagnostics Ltd(ASX:AT1) pay dividends? If so, how much?
Atomo Diagnostics Ltd(ASX:AT1) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| GHIF portfolio company Atomo Diagnostics Limited listed today on Australian Securities Exchange | 2020-04-16 |
Articles on Atomo Diagnostics Ltd
No articles.